Comeback Time for KALY (Kali, Inc.)

BY JUSTIN KINNEY ON JANUARY 14, 2019 . MEDIA & TECHNOLOGY, MICRO CAP INSIDER, SMALL CAPS

KALY (Kali, Inc.) saw a spectacular rise last year starting in September in sub penny land to highs near $0.04 in December the stock was a volume leader and continues to be among the top most traded OTC stocks.

On January 10 KALY announced a $100,000 wholesale order of its new Hemp4mula CBD Infused Gummies. The wholesale buyer recently ordered $100,000 of KALY’s Hemp4mula CBD Infused Chewing Gum. The wholesale buyer plans to have both the Hemp4mula CBD Infused Chewing Gum and Gummies available for sale at select retail drugstore locations and through the soon to be launched USMJ E-commerce Site from North American Cannabis Holdings, Inc. (USOTC: USMJ). In December, Kali-Extracts announced launching its own line of hemp-derived CBD infused candies and vapes under the brand name Hemp4mula. Kali-Extracts Hemp4mula CBD Infused Chewing Gum will come in a blister back of 8 pieces with 10 mg each of hemp-derived CBD. Kali-Extracts Hemp4mula CBD Infused Gummies will come in a container of 30 pieces with 10 mg each of hemp-derived CBD. Kali-Extracts expects to soon produce hemp-derived CBD infused mints in addition the chewing gum and gummies. Hemp4mula vapes are anticipated to also soon be in production

KALY is an exciting story developing in small caps; the Company is making some big moves recently acquiring NCM Biotech and entered into discussions with Puration and Nouveau Life to explore forming a joint venture company between the three to develop cannabis pharmaceutical products.

Last year KALY announced an LOI to acquire NCM Biotech. NCM Biotech has developed a patented cannabis extraction process – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.” NCM’s process has been engaged in a number of medical and pharmaceutical research and development projects in addition to being licensed to Puration, Inc. (USOTC: PURA) for commercial applications.

The acquisition plans contemplate NCM management assuming the senior management positions at Kali in conjunction with the planned acquisition. NCM Biotech’s medical advisory team includes John N. Gaitanis, MD., Director of Child Neurology at Tufts Medical Center/Floating Hospital for Children; Lloyd R. Saberski, M.D., Associate Professor of Anesthesiology and Chronic Pain Management, Yale University, and John McMichael, Ph.D., President & CEO Beech Tree Labs.

Kali plans to pursue pharmaceutical and other commercial applications of its patented extraction process building on the success of its current research projects and its success with Puration. Kali maintains assets and operations today in the marina management business of which it plans to divest in conjunction with the planned acquisition of NCM Biotech.

PURA recently introduced its all new EVERx CBD Sports Water Bullet Bottles to ring in the new year. EVERx has been undergoing an all around update after reaching over a million dollars in annual sales. The EVERx logo has been refreshed, with patented cannabis extraction partner Kali-Extracts (USOTC: KALY), the EVERx formula has been improved, and with copacker partner Alkame Holdings, (USOTC: ALKM) and their new state-of-the-art bottling production line, EVERx now has an entirely new bottle. Look for an announcement next week about an upcoming live event to celebrate the $1 million sales milestone and introduce the all new EVERx CBD Sports Water.

KALY recently acquired a biotech company with a patented cannabis extraction process. Accordingly, KALY updated its overall business plan (a presentation on the company’s updated business plan is available on KALY’s website). Hemp4mula is part of the updated business plan which management is rapidly executing. The company recently announced a $300,000 hemp-derived CBD extraction contract with Puration, Inc. The CBD Kali-extracts will produce is to support PURA’s contract to produce a private labeled CBD infused Water for Generex Biotechnology.

Currently trading at a $15.8 million market valuation KALY currently has a skull & crossbones designation from OTCMarketsgroup and their filings are out of date. But KALY is an exciting story developing in small caps; KALY just announced a $100,000 wholesale order of its new Hemp4mula CBD Infused Gummies. The wholesale buyer recently ordered $100,000 of KALY’s Hemp4mula CBD Infused Chewing Gum. We will be updating on KALY when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with KALY.

Disclosure: we hold no position in KALY either long or short and we have not been compensated for this article.

Original Source: https://microcapdaily.com/comeback-time-for-kaly-kali-inc/122961/

Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Oct 2024 to Nov 2024